Discounted Cash Flow (DCF) Analysis Levered
P3 Health Partners Inc. (PIII)
$1.26
+0.01 (+0.80%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2019 Actual | 2020 Actual | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Revenue | 145.48 | 485.54 | 1,620.48 | 5,408.28 | 18,049.95 | 60,241.04 | 201,052.29 | 671,004.76 |
---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||
Operating Cash Flow | -28.29 | -24.60 | -198.58 | -662.76 | -2,211.93 | -7,382.22 | -24,637.89 | -82,228.08 |
Operating Cash Flow (%) | ||||||||
Capital Expenditure | -1.45 | -2.93 | -12.97 | -43.29 | -144.46 | -482.15 | -1,609.14 | -5,370.45 |
Capital Expenditure (%) | ||||||||
Free Cash Flow | -29.74 | -27.52 | -211.55 | -706.04 | -2,356.39 | -7,864.37 | -26,247.03 | -87,598.53 |
Weighted Average Cost Of Capital
Share price | $ 1.26 |
---|---|
Beta | 0.000 |
Diluted Shares Outstanding | 68.16 |
Cost of Debt | |
Tax Rate | 9.49 |
After-tax Cost of Debt | 4.53% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 3.640 |
Total Debt | 89.92 |
Total Equity | 85.88 |
Total Capital | 175.80 |
Debt Weighting | 51.15 |
Equity Weighting | 48.85 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2019 Actual | 2020 Actual | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
Revenue | 145.48 | 485.54 | 1,620.48 | 5,408.28 | 18,049.95 | 60,241.04 | 201,052.29 | 671,004.76 |
---|---|---|---|---|---|---|---|---|
Operating Cash Flow | -28.29 | -24.60 | -198.58 | -662.76 | -2,211.93 | -7,382.22 | -24,637.89 | -82,228.08 |
Capital Expenditure | -1.45 | -2.93 | -12.97 | -43.29 | -144.46 | -482.15 | -1,609.14 | -5,370.45 |
Free Cash Flow | -29.74 | -27.52 | -211.55 | -706.04 | -2,356.39 | -7,864.37 | -26,247.03 | -87,598.53 |
WACC | ||||||||
PV LFCF | -229.21 | -734.92 | -2,356.39 | -7,555.35 | -24,224.91 | -77,672.95 | ||
SUM PV LFCF | -103,873.88 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 4.09 |
Free cash flow (t + 1) | -89,350.50 |
Terminal Value | -4,275,143.58 |
Present Value of Terminal Value | -3,498,691.60 |
Intrinsic Value
Enterprise Value | -3,602,565.48 |
---|---|
Net Debt | -50.56 |
Equity Value | -3,602,514.92 |
Shares Outstanding | 68.16 |
Equity Value Per Share | -52,854.16 |